Internationality
|
Dose-response to salbutamol via a novel palm sized nebuliser (Aerodose® Inhaler), conventional nebuliser (Pari LC Plus) and metered dose inhaler (Ventolin™ Evohaler™) in moderate to severe asthmatics
|
Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype
|
Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients
|
Retrospective population pharmacokinetics of levocetirizine in atopic children receiving cetirizine : the ETAC® study
|
Pharmacokinetics of saquinavir hard gel/ritonavir (1000/100 mg twice daily) when administered with tenofovir diproxil fumarate in HIV-1-infected subjects
|
Population pharmacokinetics of epinastine, a histamine H1 receptor antagonist, in adults and children
|
The effect of sepsis upon gentamicin pharmacokinetics in neonates
|
The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects
|
Authors' note
|
The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects
|
Bioavailability of diclofenac potassium at low doses
|
An oral yohimbine/L-arginine combination (NMI 861) for the treatment of male erectile dysfunction : a pharmacokinetic, pharmacodynamic and interaction study with intravenous nitroglycerine in healthy male subjects
|
A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery disease
|
A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin
|
National differences in publishing papers on adverse drug reactions
|
National Prescribing Service : creating an implementation arm for national medicines policy
|
Elsevier's Dictionary of Abbreviations, Acronyms, Synonyms and Symbols Used in Medicine, 2nd enlarged edition
|
Increased risk of gastrointestinal adverse effects under SSRI/NSAID combination may be due to pharmacokinetic interactions
|
Increased risk of gastrointestinal adverse effects under SSRI/NSAID combination may be due to pharmacokinetic interactions
|
Pilsicainide in breast milk from a mother : comparison with disopyramide and propafenone
|
Novel identified SNPs in the main ABC transporter ABCG2 (BCRP)
|
A pharmacy dispensing error leading to hyoscine hydrobromide overdoses
|
Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients
|
Characterizing the interaction between mycophenolate mofetyl and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling
|
Effect of inhaled AVE5883, a dual NK1/NK2 receptor antagonist, on airway responsiveness to neurokinin a in asthma
|
Two fatal intoxications following ricin injection
|
Disease severity of asthma/copd and risk of osteoporotic fractures
|
Trends in the use of ACE-inhibitors in the elderly in the netherlands, 1993–1999 : the increase of Me-too prescriptions
|
Improving treatment for patients with chronic heart failure or hypertension in general practice
|
Inosine triphosphate pyrophosphatase gene mutation predicts myelosuppression in azathioprine treated inflammatory bowel disease patients
|
The new medicine reimbursement procedure in Belgium : evaluation of two years of activity
|
Proteomics in patients with colorectal cancer : detection of biomarker proteins discriminating patients from healthy controls
|
The interaction between the preferential COX-2 inhibitor meloxicam and aspirin is statistically significant but not clinically relevant
|
An assessment of the provision of therapeutic information in physician consultation letters
|
Proteomics in patients with breast cancer : unique profile discriminates patients from matched controls
|
Determinants of angiotensin-2 antagonists prescribing in general practice
|
Self-medication with antibiotics in Europe
|
Population pharmacokinetics of phenobarbital in neonates
|
Little evidence for evidence-based medicine in the treatment of acute intoxications
|
Interactions between genetic polymorphisms and antihypertensive drugs in the treatment of hypertension
|
The need to change prescribing behaviour according to dutch and European guidelines on the management of hypercholesterolemia
|
Fast discontinuation of hypnosedative medications in geriatric inpatients
|
Pharmacokinetic study of three different doses of a new formulation of andriol testocaps® (testosterone undecanoate), in caucasian and Japanese postmenopausal women
|
The effect of rosiglitazone on the vascular response to hyperinsulinaemia in non-diabetic subjects with the metabolic syndrome
|
Patients' opinion of their diabetes control is associated with frequency of test strips use
|
A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema (HAE)
|
Evaluation of a mental stress test as a tool in clinical drug research
|
Non-compliance with antihypertensive drugs is associated with discontinuation of antihypertensive drugs
|
In vivo assessment of calcitonin gene-related peptide receptor antagonists in man
|
Renal impairment after intentional overdose with valacyclovir
|
Saturable binding of indisulam to plasma proteins and uptake in human erythrocytes
|